Genopliv ApS
Private limited companyCVR 43711172HolbækActive
Genopliv ApS is a private limited company, based in Holbæk, active in wholesale of medical and hospital supplies, founded in 2022. Net profit fell 31% from 2024 to 2025, ending at DKK 117k.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 15% (2024 → 2025), to DKK 1m.
- Net profit fell 31% (2024 → 2025), to DKK 117k.
- Equity rose 9% (2024 → 2025), to DKK 725k.
Employees
- 2 more employees than a year earlier: 4 (07/2026) against 2 (07/2025).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | 1,301 | 1,214 | 1,032 | −15% |
| Operating profit (EBIT) | 643 | 246 | 259 | +5.4% |
| Profit before tax | 634 | 218 | 179 | −17.9% |
| Net profit | 492 | 171 | 117 | −31.3% |
| Total assets | 1,154 | 1,341 | 1,456 | +8.5% |
| Equity | 532 | 663 | 725 | +9.5% |
| Liabilities | 622 | 679 | 730 | +7.6% |
| Cash and cash equivalents | 295 | 420 | 166 | −60.4% |
| Average number of employees | 1 | 1 | 1 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 22/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 13/06/2025 | The company | PDFXBRL |
| 2023 | 08/12/2022 – 31/12/2023 | 12/03/2024 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
187 companies in the databaseComparison with the other companies in wholesale of medical and hospital supplies based on the latest financial year.
Industry median: gross profit DKK 5.8m, net profit DKK 1.2m, equity DKK 5.4m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 44,207of 69,742 Better than 37% | No. 37,805of 69,964 Better than 46% |
| Same industry and fewer than 20 employees139 companies in the comparison | No. 113of 139 Better than 19% | No. 105of 139 Better than 25% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 8,967of 16,614 Better than 46% | No. 4,750of 16,661 Better than 71% |
| All companies of type ApS66,508 companies in the comparison | No. 42,576of 66,379 Better than 36% | No. 33,670of 66,505 Better than 49% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of medical and hospital supplies- Genopliv ApSDKK 1m
- Orifarm Generics A/SDKK 399.8m
- 3shape Trios A/SDKK 203.5m
- Genopliv ApSDKK 117k
- Orifarm Generics A/SDKK 77.2m
- 3shape Trios A/SDKK 58.4m
- Genopliv ApSDKK 725k
- Orifarm Generics A/SDKK 496.3m
- 3shape Trios A/SDKK 121.7m
- Genopliv ApS4
- Orifarm Generics A/S255
- 3shape Trios A/S56
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Kim Janos Pedersen100%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Kim Janos Pedersen | Director | 08/12/2022 |
- Founders
- Kim Janos Pedersen
Signing rule: Selskabet tegnes af en direktør.
Address and production units
1 active production unitsØsterled 28A
4300 Holbæk
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Genopliv ApS | Østerled 28A, 2, 4300 Holbæk | 3 | 1028841589 |
Purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
The purpose is quoted from the register in Danish.
Changes year by year
8 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20251 changeaccounts 1
- AccountsAnnual report for 2024 published
20242 changesindustry 1 · accounts 1
- IndustryIndustry changed to Wholesale of medical and hospital supplies (464620)
- AccountsAnnual report for 2023 published
20231 changeaddress 1
- AddressMoved to Østerled 28A, 2, 4300 Holbæk
20223 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as Genopliv ApS
- ManagementKim Janos Pedersen appointed director
- OwnershipKim Janos Pedersen registered as owner (100%)
Related companies
Same people in management
- Hjerteassistance ApSvia Kim Janos Pedersen
Largest in the industry
- Orifarm Generics A/SDKK 399.8m
- 3shape Trios A/SDKK 203.5m
- Medtronic Danmark A/SDKK 177.9m
- Plandent A/SDKK 172m
- Alcon Nordic A/SDKK 161m
- Siemens Healthcare A/SDKK 154.9m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.